A recent article on thehorse.com highlighted a study led by Melody de Laat, PhD, from Queensland University of Technology, in Australia, where researchers sought to investigate three things:
- The tissue distribution of equine glucose-dependent insulinotropic polypeptide receptors (eGIPR)—receptors found mainly in gut that, when in the presence of glucose molecules, signals an increase in insulin secretion;
- If a GIP antagonist could block eGIPR;
- If a relationship exists between GIP concentration and obesity.
With new information, researchers feel confident in finding a way to combat equine metabolic disease. To read the full article click here.